跳至主要内容
临床试验/IRCT20200408046988N1
IRCT20200408046988N1招募中2 期

Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings: A double-blind randomized and placebo controlled trial

Gonabad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Consent to participate in the study
  • Confirmed and suspicious COVID-19 patients
  • Not participating in another clinical trial plan simultaneously

排除标准

  • Lack of consent for the study
  • Changing the other routine medications during the project

研究者

发起方
Gonabad University of Medical Sciences

相似试验